Sin3b Interacts with Myc and decreases Myc levels

Journal of Biological Chemistry

Volumn 289, Issue 32, 2014, Pages 22221-22236

  Garcia Sanz, Pablo ^a,b,c   Quintanilla, Andrea ^a   Lafita, M Carmen ^a   Moreno Bueno, Gema ^b,c   García Gutierrez, Lucia ^a   Tabor, Vedrana ^d   Varela, Ignacio ^a   Shiio, Yuzuru ^e   Larsson, Lars Gunnar ^d   Portillo, Francisco ^b   Leon, Javier ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c MD ANDERSON CANCER CENTER   (Spain)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

DOWN-REGULATION; HISTONE DEACETYLASES; ONCOGENIC TRANSCRIPTION; SECOND LEVEL; TRANSCRIPTIONAL REGULATOR;

BIOLOGY;

HDAC1 PROTEIN, HUMAN; HISTONE DEACETYLASE 1; MYC PROTEIN; MYC PROTEIN, HUMAN; REPRESSOR PROTEIN; SIN3B PROTEIN, HUMAN;

ADULT; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; BREAST TUMOR; CHEMISTRY; DISEASE COURSE; DOWN REGULATION; FEMALE; GENETICS; HEK293 CELL LINE; HUMAN; K562 CELL LINE; METABOLISM; MIDDLE AGED; ONCOGENE MYC; PAGET NIPPLE DISEASE; PROTEIN DEGRADATION; PROTEIN DOMAIN; RAT; TRANSCRIPTION INITIATION; TWO HYBRID SYSTEM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENES, MYC; HEK293 CELLS; HISTONE DEACETYLASE 1; HUMANS; K562 CELLS; MIDDLE AGED; MODELS, BIOLOGICAL; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; REPRESSOR PROTEINS; TRANSCRIPTIONAL ACTIVATION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84905833495     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.538744     Document Type: Article

References (60)

1. Meyer, N., and Penn, L. Z. (2008) Reflecting on 25 years with MYC. Nat. Rev. Cancer 8, 976-990
2. Dang, C. V. (2012) MYC on the path to cancer. Cell 149, 22-35
3. Conacci-Sorrell, M., McFerrin, L., and Eisenman, R. N. (2014) An overview of MYC and its interactome. Cold Spring Harb. Perspect. Med. 4, a014357
4. Zeller, K. I., Zhao, X., Lee, C. W., Chiu, K. P., Yao, F., Yustein, J. T., Ooi, H. S., Orlov, Y. L., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., Kuznetsov, V. A., Sung, W. K., Ruan, Y., Dang, C. V., and Wei, C. L. (2006) Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. U.S.A. 103, 17834-17839
5. Orian, A., van Steensel, B., Delrow, J., Bussemaker, H. J., Li, L., Sawado, T., Williams, E., Loo, L. W., Cowley, S. M., Yost, C., Pierce, S., Edgar, B. A., Parkhurst, S. M., and Eisenman, R. N. (2003) Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17, 1101-1114
6. Li, Z., Van Calcar, S., Qu, C., Cavenee, W. K., Zhang, M. Q., and Ren, B. (2003) A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. U.S.A. 100, 8164-8169
7. Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., and Amati, B. (2003) Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115-1129
8. Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D. R., Tessarollo, L., Casellas, R., Zhao, K., and Levens, D. (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151, 68-79
9. Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., and Young, R. A. (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56-67
10. Eilers, M., and Eisenman, R. N. (2008) Myc's broad reach. Genes Dev. 22, 2755-2766
11. Patel, J. H., Loboda, A. P., Showe, M. K., Showe, L. C., and McMahon, S. B. (2004) Analysis of genomic targets reveals complex functions of MYC. Nat. Rev. Cancer 4, 562-568
12. Dang, C. V., O'Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., and Li, F. (2006) The c-Myc target gene network. Semin. Cancer Biol. 16, 253-264
13. Leon, J., Ferrandiz, N., Acosta, J. C., and Delgado, M. D. (2009) Inhibition of cell differentiation: a critical mechanism for MYC-mediated carcinogenesis? Cell Cycle 8, 1148-1157.
14. Nesbit, C. E., Tersak, J. M., and Prochownik, E. V. (1999) MYC oncogenes and human neoplastic disease. Oncogene 18, 3004-3016
15. Vita, M., and Henriksson, M. (2006) The Myc oncoprotein as a therapeutic target for human cancer. Semin. Cancer Biol. 16, 318-330
16. Delgado, M. D., and León, J. (2010) Myc roles in hematopoiesis and leukemia. Genes Cancer 1, 605-616
17. Hurlin, P. J., and Huang, J. (2006) The MAX-interacting transcription factor network. Semin. Cancer Biol. 16, 265-274
18. Rottmann, S., and Lüscher, B. (2006) The Mad side of the Max network: antagonizing the function of Myc and more. Curr. Top. Microbiol. Immunol. 302, 63-122
19. Grzenda, A., Lomberk, G., Zhang, J. S., and Urrutia, R. (2009) Sin3: master scaffold and transcriptional corepressor. Biochim. Biophys. Acta 1789, 443-450
20. Grandinetti, K. B., and David, G. (2008) Sin3B: an essential regulator of chromatin modifications at E2F target promoters during cell cycle withdrawal. Cell Cycle 7, 1550-1554
21. Ayer, D. E., Lawrence, Q. A., and Eisenman, R. N. (1995) Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767-776
22. Laherty, C. D., Yang, W. M., Sun, J. M., Davie, J. R., Seto, E., and Eisenman, R. N. (1997) Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89, 349-356
23. Alland, L., Muhle, R., Hou, H., Jr., Potes, J., Chin, L., Schreiber-Agus, N., and DePinho, R. A. (1997) Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49-55
24. Swanson, K. A., Knoepfler, P. S., Huang, K., Kang, R. S., Cowley, S. M., Laherty, C. D., Eisenman, R. N., and Radhakrishnan, I. (2004) HBP1 and Mad1 repressors bind the Sin3 corepressor PAH2 domain with opposite helical orientations. Nat. Struct. Mol. Biol. 11, 738-746
25. Ayer, D. E., Laherty, C. D., Lawrence, Q. A., Armstrong, A. P., and Eisenman, R. N. (1996) Mad proteins contain a dominant transcription repression domain. Mol. Cell. Biol. 16, 5772-5781
26. Heinzel, T., Lavinsky, R. M., Mullen, T. M., Söderstrom, M., Laherty, C. D., Torchia, J., Yang, W. M., Brard, G., Ngo, S. D., Davie, J. R., Seto, E., Eisenman, R. N., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43-48
27. Rao, G., Alland, L., Guida, P., Schreiber-Agus, N., Chen, K., Chin, L., Rochelle, J. M., Seldin, M. F., Skoultchi, A. I., and DePinho, R. A. (1996) Mouse Sin3A interacts with and can functionally substitute for the aminoterminal repression of the Myc antagonist Mxi1. Oncogene 12, 1165-1172
28. Gibbons, R. J. (2005) Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum. Mol. Genet. 14, R85-R92
29. Cunliffe, V. T. (2008) Eloquent silence: developmental functions of Class I histone deacetylases. Curr. Opin. Genet. Dev. 18, 404-410
30. Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693-705
31. Silverstein, R. A., and Ekwall, K. (2005) Sin3: a flexible regulator of global gene expression and genome stability. Curr. Genet. 47, 1-17
32. Nagy, L., Kao, H. Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., and Evans, R. M. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373-380
33. Rayman, J. B., Takahashi, Y., Indjeian, V. B., Dannenberg, J. H., Catchpole, S., Watson, R. J., te Riele, H., and Dynlacht, B. D. (2002) E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev. 16, 933-947
34. Xu, Y., Sengupta, P. K., Seto, E., and Smith, B. D. (2006) Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen2(I) gene (COL1A2) expression. J. Biol. Chem. 281, 9260-9270
35. David, G., Grandinetti, K. B., Finnerty, P. M., Simpson, N., Chu, G. C., and Depinho, R. A. (2008) Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proc. Natl. Acad. Sci. U.S.A. 105, 4168-4172
36. Mauleon, I., Lombard, M. N., Muñoz-Alonso, M. J., Cañelles, M., and Leon, J. (2004) Kinetics of Myc-Max-Mad gene expression during hepatocyte proliferation in vivo: differential regulation of Mad family and stress-mediated induction of c-Myc. Mol. Carcinog. 39, 85-90
37. Schuhmacher, M., Staege, M. S., Pajic, A., Polack, A., Weidle, U. H., Bornkamm, G. W., Eick, D., and Kohlhuber, F. (1999) Control of cell growth by c-Myc in the absence of cell division. Curr. Biol. 9, 1255-1258
38. Hoang, A. T., Lutterbach, B., Lewis, B. C., Yano, T., Chou, T. Y., Barrett, J. F., Raffeld, M., Hann, S. R., and Dang, C. V. (1995) A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol. 15, 4031-4042
39. Vaqué, J. P., Fernández-García, B., García-Sanz, P., Ferrandiz, N., Bretones, G., Calvo, F., Crespo, P., Marín, M. C., and León, J. (2008) c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation. Mol. Cancer Res. 6, 325-339
40. Gómez-Casares, M. T., García-Alegria, E., López-Jorge, C. E., Ferrándiz, N., Blanco, R., Alvarez, S., Vaqué, J. P., Bretones, G., Caraballo, J. M., Sánchez- Bailón, P., Delgado, M. D., Martín-Perez, J., Cigudosa, J. C., and León, J. (2013) MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27(KIP1.). Oncogene 32, 2239-2246
41. Blackwood, E. M., and Eisenman, R. N. (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251, 1211-1217
42. Kiessling, A., Sperl, B., Hollis, A., Eick, D., and Berg, T. (2006) Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules. Chem. Biol. 13, 745-751
43. Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K. J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L. G., and Landegren, U. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000
44. Quinlan, A. R., and Hall, I. M. (2010) BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842
45. Delgado, M. D., Lerga, A., Cañelles, M., Gómez-Casares, M. T., and León, J. (1995) Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene 10, 1659-1665
46. Weibrecht, I., Leuchowius, K. J., Clausson, C. M., Conze, T., Jarvius, M., Howell, W. M., Kamali-Moghaddam, M., and Söderberg, O. (2010) Proximity ligation assays: a recent addition to the proteomics toolbox. Expert Rev. Proteomics 7, 401-409
47. Hopewell, R., and Ziff, E. B. (1995) The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max. Mol. Cell. Biol. 15, 3470-3478
48. Martinato, F., Cesaroni, M., Amati, B., and Guccione, E. (2008) Analysis of Myc-induced histone modifications on target chromatin. PLoS ONE 3, e3650
49. Vervoorts, J., Lüscher-Firzlaff, J. M., Rottmann, S., Lilischkis, R., Walsemann, G., Dohmann, K., Austen, M., and Lüscher, B. (2003) Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4, 484-490
50. Patel, J. H., Du, Y., Ard, P. G., Phillips, C., Carella, B., Chen, C. J., Rakowski, C., Chatterjee, C., Lieberman, P. M., Lane, W. S., Blobel, G. A., and Mc-Mahon, S. B. (2004) The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol. Cell. Biol. 24, 10826-10834
51. Faiola, F., Liu, X., Lo, S., Pan, S., Zhang, K., Lymar, E., Farina, A., and Martinez, E. (2005) Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol. Cell. Biol. 25, 10220-10234
52. Menssen, A., Hydbring, P., Kapelle, K., Vervoorts, J., Diebold, J., Lüscher, B., Larsson, L. G., and Hermeking, H. (2012) The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc. Natl. Acad. Sci. U.S.A. 109, E187-E196
53. Nascimento, E. M., Cox, C. L., MacArthur, S., Hussain, S., Trotter, M., Blanco, S., Suraj, M., Nichols, J., Kübler, B., Benitah, S. A., Hendrich, B., Odom, D. T., and Frye, M. (2011) The opposing transcriptional functions of Sin3a and c-Myc are required to maintain tissue homeostasis. Nat. Cell Biol. 13, 1395-1405
54. Grandinetti, K. B., Jelinic, P., DiMauro, T., Pellegrino, J., Fernández Rodríguez, R., Finnerty, P. M., Ruoff, R., Bardeesy, N., Logan, S. K., and David, G. (2009) Sin3B expression is required for cellular senescence and is upregulated upon oncogenic stress. Cancer Res. 69, 6430-6437
55. Le Guezennec, X., Vermeulen, M., and Stunnenberg, H. G. (2006) Molecular characterization of Sin3 PAH-domain interactor specificity and identification of PAH partners. Nucleic Acids Res. 34, 3929-3937
56. Herbst, A., Hemann, M. T., Tworkowski, K. A., Salghetti, S. E., Lowe, S. W., and Tansey, W. P. (2005) A conserved element in Myc that negatively regulates its proapoptotic activity. EMBO Rep. 6, 177-183
57. Kurland, J. F., and Tansey, W. P. (2008) Myc-mediated transcriptional repression by recruitment of histone deacetylase. Cancer Res. 68, 3624-3629
58. Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W. L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., Chen, F., Feiler, H., Tokuyasu, T., Kingsley, C., Dairkee, S., Meng, Z., Chew, K., Pinkel, D., Jain, A., Ljung, B. M., Esserman, L., Albertson, D. G., Waldman, F. M., and Gray, J. W. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10, 529-541
59. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H., and Bernards, R. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009
60. Perreard, L., Fan, C., Quackenbush, J. F., Mullins, M., Gauthier, N. P., Nelson, E., Mone, M., Hansen, H., Buys, S. S., Rasmussen, K., Orrico, A. R., Dreher, D., Walters, R., Parker, J., Hu, Z., He, X., Palazzo, J. P., Olopade, O. I., Szabo, A., Perou, C. M., and Bernard, P. S. (2006) Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res. 8, R23